Seamless Data: Tidepool and Abbott’s New Cloud-to-Cloud Integration Partnership
Tidepool has announced a new cloud-to-cloud data integration partnership with Abbott (NYSE: ABT) for continuous glucose monitoring (CGM). The integration will enable automatic data streaming from Abbott's FreeStyle Libre CGM devices to Tidepool+, a diabetes data visualization and population health platform. This partnership allows healthcare providers to initiate connections with patients using FreeStyle Libre 1, 2, and 3 devices, both in-clinic and remotely. The integration aims to streamline diabetes care workflows and provide comprehensive patient data overview through Tidepool's Population Health Dashboard.
Tidepool ha annunciato una nuova partnership di integrazione dati cloud-to-cloud con Abbott (NYSE: ABT) per il monitoraggio continuo della glicemia (CGM). L'integrazione permetterà lo streaming automatico dei dati dai dispositivi CGM FreeStyle Libre di Abbott a Tidepool+, una piattaforma di visualizzazione dei dati per il diabete e la salute della popolazione. Questa partnership consente ai fornitori di assistenza sanitaria di avviare connessioni con i pazienti che utilizzano i dispositivi FreeStyle Libre 1, 2 e 3, sia in clinica che a distanza. L'integrazione punta a semplificare i flussi di lavoro nella cura del diabete e a fornire una panoramica completa dei dati dei pazienti tramite il Dashboard per la Salute della Popolazione di Tidepool.
Tidepool ha anunciado una nueva asociación de integración de datos de nube a nube con Abbott (NYSE: ABT) para el monitoreo continuo de glucosa (CGM). La integración permitirá la transmisión automática de datos desde los dispositivos CGM FreeStyle Libre de Abbott a Tidepool+, una plataforma de visualización de datos de diabetes y salud poblacional. Esta asociación permite a los proveedores de atención médica iniciar conexiones con los pacientes que utilizan los dispositivos FreeStyle Libre 1, 2 y 3, tanto en la clínica como de manera remota. La integración tiene como objetivo simplificar los flujos de trabajo en el cuidado de la diabetes y proporcionar una visión completa de los datos del paciente a través del Panel de Salud Poblacional de Tidepool.
타이드풀은 연속 혈당 모니터링(CGM)을 위해 앱부트 (NYSE: ABT)와 클라우드 간 데이터 통합 파트너십을 발표했습니다. 이 통합을 통해 Abbott의 FreeStyle Libre CGM 장치에서 Tidepool+으로 자동 데이터 스트리밍이 가능해집니다. 이 파트너십은 의료 제공자가 클리닉 안팎에서 FreeStyle Libre 1, 2 및 3 장치를 사용하는 환자와 연결을 시작할 수 있도록 합니다. 이 통합은 당뇨병 치료 워크플로를 간소화하고 Tidepool의 인구 건강 대시보드를 통해 포괄적인 환자 데이터 개요를 제공하는 것을 목표로 합니다.
Tidepool a annoncé un nouveau partenariat d'intégration de données cloud-à-cloud avec Abbott (NYSE: ABT) pour le monitoring continu de la glucose (CGM). L'intégration permettra le streaming automatique des données des dispositifs CGM FreeStyle Libre d'Abbott vers Tidepool+, une plateforme de visualisation des données sur le diabète et la santé de la population. Ce partenariat permet aux professionnels de la santé d'initier des connexions avec les patients utilisant les dispositifs FreeStyle Libre 1, 2 et 3, que ce soit en clinique ou à distance. L'intégration vise à simplifier les flux de travail de soin du diabète et à fournir une vue d'ensemble complète des données des patients via le tableau de bord de la Santé de la Population de Tidepool.
Tidepool hat eine neue Cloud-to-Cloud-Datenintegrationspartnerschaft mit Abbott (NYSE: ABT) für die kontinuierliche Glukoseüberwachung (CGM) angekündigt. Die Integration ermöglicht das automatische Streamen von Daten von Abbots FreeStyle Libre CGM-Geräten zu Tidepool+, einer Plattform zur Datenvisualisierung für Diabetes und Bevölkerungsgesundheit. Diese Partnerschaft ermöglicht es Gesundheitsdienstleistern, Verbindungen zu Patienten herzustellen, die die Geräte FreeStyle Libre 1, 2 und 3 sowohl in der Klinik als auch aus der Ferne nutzen. Ziel der Integration ist es, die Arbeitsabläufe in der Diabetesversorgung zu optimieren und eine umfassende Übersicht über die Patientendaten über das Bevölkerungsgesundheits-Dashboard von Tidepool zu bieten.
- New cloud-to-cloud integration partnership enhances Abbott's data accessibility
- Expansion of FreeStyle Libre CGM ecosystem through Tidepool+ platform integration
- Streamlined workflow automation potential for healthcare providers
- None.
Insights
This cloud-to-cloud integration partnership between Tidepool and Abbott represents an incremental improvement in diabetes care management but has immediate financial impact. The integration with FreeStyle Libre devices will enhance Abbott's competitive position in the CGM market by offering improved data accessibility and management tools.
The partnership strengthens Abbott's ecosystem by providing seamless data integration capabilities, potentially increasing user retention and satisfaction. However, as Tidepool is a nonprofit organization, the revenue implications are minimal. The real value lies in the operational efficiency for healthcare providers and improved patient experience, which could indirectly support Abbott's market share in the long term.
While strategically sound, this integration is more of a feature enhancement than a significant market catalyst. Abbott's FreeStyle Libre franchise, which generates over
Tidepool partners with Abbott for seamless data integration, expanding patient choice, and streamlining diabetes care workflows.
Tidepool+, a diabetes data visualization and population health platform, provides intuitive tracking and visualization of diabetes data making the data informative and actionable for clinicians, people living with diabetes, and caregivers.
“As a nonprofit organization, Tidepool is dedicated to providing better access to devices and data through interoperable solutions that give all people living with diabetes greater autonomy. We are excited to partner with Abbott to empower healthcare providers and people living with diabetes to see data from their FreeStyle Libre devices on Tidepool and Tidepool+,” said Brandon Arbiter, VP of business development and strategic partnerships at Tidepool.
All cloud-to-cloud connections for Tidepool are designed with simplicity and streamlined workflows in mind. Clinics and health systems using Tidepool+ will be able to initiate the connection with their patients using Abbott FreeStyle Libre 1, Libre 2, and Libre 3 in clinic or remotely. Tidepool+ will seamlessly merge data from Libre devices into its Population Health Dashboard and retrospective data displays, creating a comprehensive overview for clinicians to assess outcomes for their entire patient population.
Tidepool and Abbott’s new data integration partnership will simplify data sharing by automating data upload to Tidepool for patients wearing FreeStyle Libre sensors, and create more efficient workflows for clinics and health systems providing ongoing and proactive care.
About Tidepool
Tidepool is a recognized innovator in diabetes software on a mission to make diabetes data more accessible, actionable, and meaningful for people with diabetes, their care teams, and researchers. Founded in 2013, Tidepool hosts a suite of software tools for people with diabetes and the clinics that serve them, including Tidepool+, Tidepool Mobile, Tidepool Uploader, and soon Tidepool Loop. Tidepool is a registered 501(c)3 nonprofit organization. Learn more at tidepool.org. Connect with us on Linkedin, Facebook, X, and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241024402862/en/
Christopher Snider
Saira Khan-Gallo
media@tidepool.org
Source: Tidepool
FAQ
What is the new partnership between Abbott (ABT) and Tidepool?
Which Abbott (ABT) devices are compatible with the Tidepool+ integration?
How will the Abbott (ABT) and Tidepool integration benefit healthcare providers?
